Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Duxin Sun

Showing results (11-20 of 287) with videos related to

Pageof 29
Sort By:
Clinical Pharmacology and Therapeutics|May 26, 2026
Machine Learning Model Predicts Clinical Adverse Events of Small Molecule Kinase Inhibitors in Cancer Patients Using On-/Off-Target Engagement and Tissue SelectivityNatalie M Jusko, Albert Cao, Duxin Sun
Pharmaceutical Research|September 26, 2013
PLGA/liposome hybrid nanoparticles for short-chain ceramide deliveryPeng Zou, Stephan T Stern, Duxin Sun
Journal of Microencapsulation|July 27, 2007
Preparation and evaluation of biodegradable flubiprofen gelatin micro-spheres for intra-articular administrationYing Lu, Guoqing Zhang, Duxin Sun, et al.
Acta Pharmaceutica Sinica. B|September 15, 2021
Tumor-derived exosomes: Nanovesicles made by cancer cells to promote cancer metastasisHongwei Chen, Venkata Chengalvala, Hongxiang Hu, et al.
Acta Pharmaceutica Sinica. B|July 22, 2022
Why 90% of clinical drug development fails and how to improve it?Duxin Sun, Wei Gao, Hongxiang Hu, et al.
Pharmaceutical Research|August 2, 2024
Machine Learning Prediction of On/Off Target-driven Clinical Adverse EventsAlbert Cao, Luchen Zhang, Yingzi Bu, et al.
Clinical Pharmacology : Advances and Applications|July 17, 2020
Pharmacokinetic Disposition Difference Between Cyclosporine and Voclosporin Drives Their Distinct Efficacy and Safety Profiles in Clinical StudiesYan Li, Maria Palmisano, Duxin Sun, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 24, 2010
In vitro metabolism of 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin in human liver microsomesNan Zheng, Peng Zou, Shaomeng Wang, et al.
Pharmacology Research & Perspectives|March 16, 2016
Slow drug delivery decreased total body clearance and altered bioavailability of immediate- and controlled-release oxycodone formulationsYan Li, Duxin Sun, Maria Palmisano, et al.
Nutrition and Cancer|August 31, 2011
Sulforaphane potentiates the efficacy of 17-allylamino 17-demethoxygeldanamycin against pancreatic cancer through enhanced abrogation of Hsp90 chaperone functionYanyan Li, Tao Zhang, Steven J Schwartz, et al.
Pageof 29

Showing results (11-20 of 287) with videos related to

Sort By:
Pageof 29
Clinical Pharmacology and Therapeutics|May 26, 2026
Machine Learning Model Predicts Clinical Adverse Events of Small Molecule Kinase Inhibitors in Cancer Patients Using On-/Off-Target Engagement and Tissue SelectivityNatalie M Jusko, Albert Cao, Duxin Sun
Pharmaceutical Research|September 26, 2013
PLGA/liposome hybrid nanoparticles for short-chain ceramide deliveryPeng Zou, Stephan T Stern, Duxin Sun
Journal of Microencapsulation|July 27, 2007
Preparation and evaluation of biodegradable flubiprofen gelatin micro-spheres for intra-articular administrationYing Lu, Guoqing Zhang, Duxin Sun, et al.
Acta Pharmaceutica Sinica. B|September 15, 2021
Tumor-derived exosomes: Nanovesicles made by cancer cells to promote cancer metastasisHongwei Chen, Venkata Chengalvala, Hongxiang Hu, et al.
Acta Pharmaceutica Sinica. B|July 22, 2022
Why 90% of clinical drug development fails and how to improve it?Duxin Sun, Wei Gao, Hongxiang Hu, et al.
Pharmaceutical Research|August 2, 2024
Machine Learning Prediction of On/Off Target-driven Clinical Adverse EventsAlbert Cao, Luchen Zhang, Yingzi Bu, et al.
Clinical Pharmacology : Advances and Applications|July 17, 2020
Pharmacokinetic Disposition Difference Between Cyclosporine and Voclosporin Drives Their Distinct Efficacy and Safety Profiles in Clinical StudiesYan Li, Maria Palmisano, Duxin Sun, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 24, 2010
In vitro metabolism of 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin in human liver microsomesNan Zheng, Peng Zou, Shaomeng Wang, et al.
Pharmacology Research & Perspectives|March 16, 2016
Slow drug delivery decreased total body clearance and altered bioavailability of immediate- and controlled-release oxycodone formulationsYan Li, Duxin Sun, Maria Palmisano, et al.
Nutrition and Cancer|August 31, 2011
Sulforaphane potentiates the efficacy of 17-allylamino 17-demethoxygeldanamycin against pancreatic cancer through enhanced abrogation of Hsp90 chaperone functionYanyan Li, Tao Zhang, Steven J Schwartz, et al.
Pageof 29